Patents by Inventor Rovil Arcia
Rovil Arcia has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 11478353Abstract: A system for treating a heart includes a catheter that is advanceable into a chamber of the heart and that is repositionable within the chamber between a septal wall and an external wall to enable penetration of the septal and external walls via a needle that is disposed within a lumen of the catheter. A first guidewire is deliverable through the penetration of the septal wall so that a distal end of the first guidewire is disposed within another chamber of the heart. A second guidewire is deliverable through the penetration of the external wall so that a distal end of the second guidewire is disposed externally of the external wall. The first guidewire is connectable to the second guidewire to join or form a path within the chamber that extends between the septal wall and the external wall.Type: GrantFiled: January 27, 2017Date of Patent: October 25, 2022Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Serjan Nikolic, Lon Annest, Rovil Arcia
-
Publication number: 20220000622Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: June 17, 2021Publication date: January 6, 2022Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 11051942Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: GrantFiled: January 8, 2019Date of Patent: July 6, 2021Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 11051941Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue in a minimally invasive manner, often for treatment of congestive heart failure. In one embodiment, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface of the heart. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a delivery catheter. Delivering the anchor over the guidewire may provide improved control in the delivery and placement of the anchor within the right ventricle.Type: GrantFiled: November 2, 2015Date of Patent: July 6, 2021Assignee: BioVentrix, Inc.Inventors: Lon Annest, Murray Sheldon, Kevin Van Bladel, Ernie Heflin, William Butler, Andrew Wechsler, John Bower, Rovil Arcia
-
Publication number: 20190274833Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: January 8, 2019Publication date: September 12, 2019Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 10219904Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue, often for treatment of congestive heart failure. In one embodiment an anchor of an implant system may reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a catheter. An anchor force may be applied within a desired range to secure the anchors about the septum and epicardial surface. The anchor force may inhibit migration of the anchors relative to the septum and epicardial surface.Type: GrantFiled: November 2, 2015Date of Patent: March 5, 2019Assignee: BioVentrix, Inc.Inventors: William Butler, Kevin Van Bladel, Ernie Heflin, Lon Annest, Rovil Arcia, John Bower
-
Patent number: 10179049Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: GrantFiled: April 24, 2017Date of Patent: January 15, 2019Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 9937043Abstract: Embodiments described herein provide devices, systems, and methods that reduce the distance between two locations in tissue, often for treatment of congestive heart failure. For example, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. The anchor may be deployed into the heart through a working lumen of a minimally invasive access tool. The minimally invasive access tool may have a plurality of grippers near a distal end of the working lumen. The grippers may engage epicardial tissue of the heart and may be moved radially inwardly relative so as to provide stabilization of the epicardial tissue and/or hemostasis near an access site where the anchor is inserted through the epicardium. The minimally invasive access tool may minimize blood loss from the access site and improve anchor implant processes.Type: GrantFiled: July 31, 2015Date of Patent: April 10, 2018Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, John Stiggelbout, Rovil Arcia
-
Publication number: 20170224490Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: April 24, 2017Publication date: August 10, 2017Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Publication number: 20170216032Abstract: A system for treating a heart includes a catheter that is advanceable into a chamber of the heart and that is repositionable within the chamber between a septal wall and an external wall to enable penetration of the septal and external walls via a needle that is disposed within a lumen of the catheter. A first guidewire is deliverable through the penetration of the septal wall so that a distal end of the first guidewire is disposed within another chamber of the heart. A second guidewire is deliverable through the penetration of the external wall so that a distal end of the second guidewire is disposed externally of the external wall. The first guidewire is connectable to the second guidewire to join or form a path within the chamber that extends between the septal wall and the external wall.Type: ApplicationFiled: January 27, 2017Publication date: August 3, 2017Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Serjan Nikolic, Lon Annest, Rovil Arcia
-
Patent number: 9662212Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: GrantFiled: April 15, 2016Date of Patent: May 30, 2017Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Publication number: 20160338835Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: April 15, 2016Publication date: November 24, 2016Applicant: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 9320513Abstract: Embodiments described include devices, systems, and methods for reducing the distance between two locations in tissue. An anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: GrantFiled: March 13, 2015Date of Patent: April 26, 2016Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Publication number: 20160095600Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue in a minimally invasive manner, often for treatment of congestive heart failure. In one embodiment, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface of the heart. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a delivery catheter. Delivering the anchor over the guidewire may provide improved control in the delivery and placement of the anchor within the right ventricle.Type: ApplicationFiled: November 2, 2015Publication date: April 7, 2016Inventors: Lon Annest, Murray Sheldon, Kevin Van Bladel, Ernie Heflin, William Butler, Andrew Wechsler, John Bower, Rovil Arcia
-
Publication number: 20160089132Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue, often for treatment of congestive heart failure. In one embodiment an anchor of an implant system may reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a catheter. An anchor force may be applied within a desired range to secure the anchors about the septum and epicardial surface. The anchor force may inhibit migration of the anchors relative to the septum and epicardial surface.Type: ApplicationFiled: November 2, 2015Publication date: March 31, 2016Inventors: William Butler, Kevin Van Bladel, Ernie Heflin, Lon Annest, Rovil Arcia, John Bower
-
Publication number: 20160030026Abstract: Embodiments described herein provide devices, systems, and methods that reduce the distance between two locations in tissue, often for treatment of congestive heart failure. For example, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. The anchor may be deployed into the heart through a working lumen of a minimally invasive access tool. The minimally invasive access tool may have a plurality of grippers near a distal end of the working lumen. The grippers may engage epicardial tissue of the heart and may be moved radially inwardly relative so as to provide stabilization of the epicardial tissue and/or hemostasis near an access site where the anchor is inserted through the epicardium. The minimally invasive access tool may minimize blood loss from the access site and improve anchor implant processes.Type: ApplicationFiled: July 31, 2015Publication date: February 4, 2016Inventors: Kevin Van Bladel, Lon Annest, John Stiggelbout, Rovil Arcia
-
Patent number: 9173711Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue, often for treatment of congestive heart failure. In one embodiment an anchor of an implant system may reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a catheter. An anchor force may be applied within a desired range to secure the anchors about the septum and epicardial surface. The anchor force may inhibit migration of the anchors relative to the septum and epicardial surface.Type: GrantFiled: September 30, 2012Date of Patent: November 3, 2015Assignee: BioVentrix, Inc.Inventors: William Butler, Kevin Van Bladel, Ernie Heflin, Lon Annest, Rovil Arcia, John Bower
-
Patent number: 9173712Abstract: Medical devices, systems, and methods reduce the distance between two locations in tissue in a minimally invasive manner, often for treatment of congestive heart failure. In one embodiment, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along an epicardial surface of the heart. Deployment of the anchor within the right ventricle may be performed by inserting a guidewire through the septal wall into the right ventricle. The anchor may be inserted into the right ventricle over the guidewire and through a lumen of a delivery catheter. Delivering the anchor over the guidewire may provide improved control in the delivery and placement of the anchor within the right ventricle.Type: GrantFiled: September 30, 2012Date of Patent: November 3, 2015Assignee: BioVentrix, Inc.Inventors: Lon Annest, Murray Sheldon, Kevin Van Bladel, Ernie Heflin, William Butler, Andrew Wechsler, John Bower, Rovil Arcia
-
Publication number: 20150282802Abstract: Embodiments described herein include devices, systems, and methods for reducing the distance between two locations in tissue. In one embodiment, an anchor may reside within the right ventricle in engagement with the septum. A tension member may extend from that anchor through the septum and an exterior wall of the left ventricle to a second anchor disposed along a surface of the heart. Perforating the exterior wall and the septum from an epicardial approach can provide control over the reshaping of the ventricular chamber. Guiding deployment of the implant from along the epicardial access path and another access path into and through the right ventricle provides control over the movement of the anchor within the ventricle. The joined epicardial pathway and right atrial pathway allows the tension member to be advanced into the heart through the right atrium and pulled into engagement along the epicardial access path.Type: ApplicationFiled: March 13, 2015Publication date: October 8, 2015Inventors: Kevin Van Bladel, Lon Annest, Murray Sheldon, Ernie Heflin, Andrew Wechsler, John Stiggelbout, Rovil Arcia, John Bower
-
Patent number: 9095363Abstract: Embodiments described herein provide devices, systems, and methods that reduce the distance between two locations in tissue, often for treatment of congestive heart failure. For example, an anchor of an implant system may, when the implant system is fully deployed, reside within the right ventricle in engagement with the ventricular septum. The anchor may be deployed into the heart through a working lumen of a minimally invasive access tool. The minimally invasive access tool may have a plurality of grippers near a distal end of the working lumen. The grippers may engage epicardial tissue of the heart and may be moved radially inwardly relative so as to provide stabilization of the epicardial tissue and/or hemostasis near an access site where the anchor is inserted through the epicardium. The minimally invasive access tool may minimize blood loss from the access site and improve anchor implant processes.Type: GrantFiled: September 30, 2012Date of Patent: August 4, 2015Assignee: BioVentrix, Inc.Inventors: Kevin Van Bladel, Lon Annest, John Stiggelbout, Rovil Arcia